Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments.

1. Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics,
Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic
Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive
Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 - 2020
Biomarkers Market
Published : 10-Dec-2013 Pages: 151

2. Description
Biomarkers are novel diagnostic tools that provide intelligence to physician
about disease progression and treatment effects. Advancement in understanding
of human genome promotes its application in diagnosis of disease on molecular
basis.
Biomarker technology is evidencing increased application in disease diagnosis,
drug development and formulation, diagnosis for exposure of certain harmful
chemical and prognostic treatments.
The global market for diagnostic biomarker is expected to reach about $30.6
billion in 2020, growing at CAGR of 16% from 2013 to 2020.
Pharmaceutical companies, which are interested in introducing novel diagnostic
solution are increasing partnership and collaboration with private laboratories,
and educational institutes. The companies are also increasing their investments
in research and development.

3. Overview
Disease diagnostic application remains the key area of application that is
expected to reach 6.1 $billion in 2020.
However, application of diagnostic biomarkers in forensics and molecular
diagnostics is catching up quite significantly. Molecular diagnostics is
expected to grow at a CAGR of 17.6% from 2013 to 2020.

4. Key Benefits
• Assessment and ranking the factors that favor the market growth and those
factors which act as a hindrance for the growth of the market
• The market sizing and estimation period is from 2013 to 2020. Two historic
years include 2011 and 2012
• The report identifies and analyses top investment pockets and top winning
strategies for diagnostic biomarker market
• The report analyses the various strategies adopted by some of the key companies
in the market
• The report tracks and analyses key innovations and patents for biomarkers in the
last five years

5. Key Audiences
• Pharmaceutical companies
• Government & Private research institutes
• Academic institutes
• Medical device manufacturing companies

6. Biomarkers in Top Technologies
• Lengthy Process
• Ethical Problems
• Gene Expression
Omics Technology
• Radiation Effect
• Complex Process
• Genetic Variation
Imaging Technology
• Difficulty in Practical Application
• Over-Fitting
• Costly Management
Bioinformatics

7. Top Factors Impacting DBM Market
• Non-Invasive Technique
• Drug Discovery and Development
• Cost Effective Tool for Diagnosis
• Multi-Marker Application
• Accuracy and Reliability
• Ethical Issues
• Gene Level Diagnosis
• Complex Processes
• Government Regulations

8. Market Dynamics Drivers
• Cost Effective
• Non-Invasive
• Accuracy in Result
• Assistant in Clinical Trials
• Multi-Marker Application
• Gene Level Diagnosis

9. Diagnostic Biomarker Market By Services
Assay Development
• Complexity in Technique
• Tissue Specific
Biomarker Validation and Testing
• Clinical Errors
• Time Consuming

10. Companies
• Abbott Laboratories, Inc.
• Agilent Technologies Inc.
• Aushon Biosystem
• Bio-Rad Laboratories
• Eisai Co. Ltd.
• Epistem Ltd.
• Ge Healthcare
• Roche Diagnostics Limited

11. Market By Geography

12. Get full access of report at:
http://www.analyzefuture.com/biomarkers-market